Interleukin 12 (IL-12) produced by macrophages immediately after infection is considered essential for activation of a protective immune response against intracellular pathogens. In the murine Mycobacterium boris Bacillus Calmette-Gu~rin (BCG) model we assessed whether early IL12 production by macrophages depends on other cytokines. In vitro, murine bone marrow-derived macrophages produced IL-12 after infection with viable M. bows BCG or stimulation with LPS, however, priming with recombinant interferon 3' (rlFN-3r was necessary. In addition, IL-12 production by these macrophages was blocked by specific anti-tumor necrosis factor ix (TNF-ix) antiserum. Macrophages from gene deletion mutant mice lacking either the IFN-T receptor or the TNF receptor 1 (p55) failed to produce IL-12 in vitro after stimulation with rlFN-3' and mycobacterial infection. In vivo, IL-12 production was induced in spleens of immunocompetent mice early during M. boris BCG infection but not in those of mutant mice lacking the receptors for IFN-3' or TNF. Our results show that IL-12 production by macrophages in response to mycobacterial infection depends on IFN-T and TNF. Hence, IL-12 is not the first cytokine produced in mycobacterial infections.
D
ue to its NK cell and T cell stimulating properties, IL-12 was originally termed NK cell stimulatory factor or cytotoxic lymphocyte maturation factor (1, 2) . It is a heterodimer composed of two covalently linked chains, p35 and p40. The light chain (p35) is homologous to IL-6 and G-CSF and is constitutively expressed in several cell types including macrophages. The p40 subunit is homologous to the extracellular part of the IL-6 and G-CSF receptor (3) (4) (5) . The bioactive p70 heterodimer is produced by monocytes/macrophages and B cells and modulates various functions of mature T and NK cells including cytotoxicity and cytokine production (3, (6) (7) (8) (9) (10) . It has been shown recently that IL12 plays a decisive role in host-defense against intracellular pathogens. It is produced by infected monocytes/macrophages as one of the first host responses to infection and, together with TNF, induces IFN-3r production by NK cells (11) (12) (13) . This early IFN-3, activates macrophages and initiates differentiation of Thl cells (11, (14) (15) (16) . Development of a Thl response and IFN-T production are central to eradication of various pathogens including Leishmania major (15) , Toxoplasma gondii (17) , Listeria monocytogenes (11) , Mycobacterium tuberculosis (18) , Mycobacterium leprae (19) , and Schistosoma mansoni (20) . On the other hand, in infections characterized by protective Th2 cytokine responses IL-12 downregulates Th2 cell expansion thus exacerbating the disease (21) . We here show that the production of IL-12 by Mycobacterium bovis Bacillus Calmette-Gu~rin (BCG)l-infected macrophages in vitro and in vivo depends on prior stimulation with rlFN-3' and is mediated by endogenous TNF-IX. The strict dependence of IL-12 secretion on IFN-y and TNF-IX suggests that production of the latter cytokines must precede IL-12 secretion. Thus, macrophagederived IL-12 cannot be the first cytokine of the sequence leading to protective antimycobacterial immunity mediated by Thl cells.
shaking. Aliquots were frozen and stored at -70~ Numbers of viable organisms were determined by plating 1:10 dilutions on Middlebrook Dubos agar plates (Difco). Plates were incubated at 37~ and the numbers of colony-forming units were determined.
Reagents. Murine rlFN-3, was kindly provided by Dr. G. Adolf (Ernst Boehringer-Institut flir Arzneimittelforschung, Vienna, Austria). The specific activity was 107 U/mg protein. Murine rlL-12 was a gift from Dr. Start Wolf (Genetics Institute, Cambridge, MA). The specific activity was 5.6 x 106 U/rag protein. Aliquots of recombinant cytokines were stored in Click's/RPMI containing 10% FCS. Two rat anti-IL-12 (p40) mAb, C15.6.7 IgG1 and C17.8 IgG2a, were a generous gift of Dr. G. Trinchieri (The Wistar Institute, Philadelphia, PA). LPS from Escherichia coli was obtained from Difco. Murine rTNF-oe and polyclonal rabbit anti-mouse TNF-cx antiserum were purchased from Genzyme (Boston, MA). As a control, normal rabbit serum (NRS) was used. Oligonucleotides for IL-12 (p40) were synthesized on a DNA synthesizer (381A; Applied Biosystems, Inc., Foster City, CA). Sense: 449-CGTGCT-CATGGCTGGTGCAAAG; antisense: 761-CTTCATCTGCAAo GTTCTTGGGC.
Macwphage Cultures. Bone marrow-derived macrophages (BMM) were obtained in a serum-free culture medium as described previously (25) . BMM were harvested after 9 d and stimulated in IMDM without additives and antibiotics as indicated in Results.
DotBtotAssayforlL12(p40). Aliquots of culture supernatants
were placed into the wells of Millititer filtration plates with 0.45-#m pore size (Millipore, Eschborn, Germany) and incubated at room temperature for 1 h. Subsequently, supernatants were sucked into the membrane filters by using a vacuum filtration holder (Millipore). Wells were blocked with 3% skim milk in 50 mM Tris-HC1 buffer, pH 7.5, overnight. After three washes with PBS, aliquots of 200/A/well of biotinylated anti-IL-12 (1040) mAb C15.6.7 (1 #g/ml) were added. After incubation at room temperature for 2 h, plates were washed three times with PBS and streptavidin alkaline phosphatase (Dianova, Hamburg, Germany) (1:5,000 in 0.1% BSA in PBS) was added. After 30 rain of incubation at room temperature, plates were washed three times with PBS and the substrate p-nitrophenyl phosphate (Sigma, Mfinchen, Germany) was added. After 10 min of incubation at room temperature, the reaction was terminated with 0.5 M EDTA, pH 8.0. Aliquots were transferred into flat-bottom microdilution plates and ih05 was measured in an Immunoreader NJ 2000 (Intermed). The IL-12 content was calculated by using rlL-12 as a standard with medium alone as a blank.
ELISAfor ILl2. IL-12 was measured in a two-site ELISA. The mAb C17.8 IgG2a was used for coating and biotinylated mAb C15.6 IgG1 was employed for detection.
Semiquantitative Reverse Transc@tase (RT)~PCR-Analysis and Southern Hybridization of RT-PCR Amplified Products. Semiquantitative RT-
PCR analysis of IL-12 and/3-actin mRNA was performed as described previously in detail (26) . RT-PCR products were fractionated by electrophoresis on 1% agarose gel (0.5 x Tris-borate-EDTA). DNA was partially depurinated by 5-gel vol of 0.25 M HC1 for 10-15 min at room temperature and denatured by placing the gel in 5-gel vol of 0.4 M NaOH, 0.6 M NaC1 for 15 rain. The DNA was blotted on nylon membranes (United States Biochem. Corp., Cleveland, OH) by applying a Vacuum Blotter from Appligene (Heidelberg, Germany) using 0.4 M HC1 and 0.6 M NaC1 denaturing buffer for 1 h. Subsequently the DNA on the nylon membrane was fixed by UV cross-linking (125 mJ/cm 2) with Fluo-Link apparatus (Renner, Darmstadt, Germany) for 3 min. The hybridization probe, 1 #g IL-12 (p40) cDNA, was labeled with biotin according to standard protocols (Gene Images kit, United States Biochem. Corp.) and used for hybridization of target RT-PCR DNA products. The hybridization was performed at 42~ overnight in a hybridization oven (Biometra, G6ttingen, Germany). The washing procedure and the chemiluminescent immunodetection protocol were applied according to the manufacturer's descriptions (Gene Images kit). The signal development on x-ray film (XOMAT-AK, Kodak) was performed for 1 h. As molecular weight markers, biotinylated DNA fragments (50-1,000 bp) from Research Genetics (Huntsville, AL) were used. 
In Vivo Induction of

Results
To analyze the stimuli that are required for IL-12 production, murine BMM obtained by cultivation in a serum-free medium were used that represent a quiescent macrophage population devoid of contaminating cells like granulocytes or lymphocytes (25) . Accumulation of IL-12 in culture supernatants was analyzed by a specific ELISA with a detection limit of 200 pg/ml of IL-12 (p40). Supernatants in which IL-12 was not detectable by ELISA were analyzed by the more sensitive dot-blot assay with a detection limit of "~,50 pg/ml. It has been shown previously that the presence of the II.-12 p40 chain correlates with increased levels of the bioactive p70 heterodimer (12) .
ILl2 Produced by Macrophages In Vitro After M. bovis BCG Infection or LPS Stimulation Depends on Priming with rlFN-T.
BMM from C57BL/6 mice were primed with rlFN-3, and/or infected with M. bov/s BCG or stimulated with LPS. As shown in Table 1 synthesis (data not shown). It has been shown that LPSbinding protein is required for macrophage stimulation with LPS (27, 28). Because the rlFN-y used for macrophage priming contained minute concentrations (0.001%) of FCS, we cannot exclude formally contamination of our rlFN-3, preparation with LPS-binding protein. However, we consider the minute FCS concentration insufficient. It appears more likely that BMM stimulation with rlFN-y induced LPSbinding protein synthesis that then rendered LPS bioactive. Other cytokines tested, including rlL-4 and rlL-6, failed to prime macrophages for IL-12 synthesis (data not shown). In addition, BMM were analyzed for IL-12 mRNA expression by PCR. As shown in Fig. 1 A, IL-12 mRNA was only found in macrophages costimulated with rlFN-3, and M. bov/s BCG. Endogenous TNF-~ Regulates 11_,12 Production by BMM. We have shown previously that TNF-o~ mediates mycobacterial growth inhibition by nitric oxide (26) . To investigate the role of endogenously produced TNF-a in the induction of IL-12 synthesis, a specific polyclonal anti-TNF-oe antiserum was used. BMM were primed with rlFN-3' for 24 h and subsequently infected with M. bovis BCG or stimulated with LPS for another 24 h in the presence of anti-TNF-o~ antiserum or NRS. As shown in Fig. 2 , addition of anti-TNF-c~ antiserum during infection of rlFN-3,-primed BMM with M. bovis BCG or during stimulation with LPS significantly reduced IL-12 production. NRS used as control had no significant effect on IL12 synthesis by BMM. In parallel, IL-12 mRNA expression was analyzed in BMM stimulated with rlFN-3' and LPS in the presence of anti-TNF-a antiserum or NRS (Fig.  3) . The IL-12 mRNA expression was inhibited by incubation of macrophages with anti-TNF-ol antiserum although TNF-ot itself failed to induce IL12 synthesis by BMM (Table  1) . Hence, induction of IL12 synthesis by macrophages depended on signaling through both IFN-'y receptor and TNF receptor 1.
BMM from IFN-TR ~176 or Tnfrl ~176 Mice Fail to Produce 11.,12.
To further analyze the contribution of IFN-3' and TNF-a to IL12 production, IFN-3,R ~176 mice and Tnfrl ~176 mice were employed. BMM prepared from these mutant mice were primed for 24 h with increasing concentrations of rlFN-3' and subsequently infected with M. boris BCG or stimulated with LPS for another 24 h. Neither BMM from IFN-3,R ~176 mice nor BMM from Tnfrl ~176 mice were able to produce IL-12 at the mRNA or protein level after stimulation with rlFN-'y plus M. bov/s BCG or LPS (Table 1 and Fig. 1, B and C). These results verify that IL-12 production by macrophages in vitro exclusively depends on both, IFN-y and TNF-ol and that IFN-~/and TNF-o~ stimulation cannot be compensated by other cytokines in these mutant mice. Furthermore our data reveal that TNF receptor 1, and not TNF receptor 2, is responsible for the TNF-ol effect. for IL-12 detection. As shown in Table 2 (Fig. 4) . In vitro, stimulation of spleen cells from mutant mice with ConA, rlFN-3,, or M. bov/s BCG did not induce IL12 production (Table 2) . We conclude that IFN-3, and TNF secretion must precede early IL-12 production by macrophages during M. bov/s BCG infection.
11_:12 Induction In Viva
Discussion
According to current view, IL-12 is the first cytokine produced by macrophages infected with intracellular pathogens (11, 15, 17, 29, 30) and it is a requisite cytokine for induction of the Thl developmental pathway (15, 31) 1-4) .
suggest that IL-12 is not the first cytokine produced in response to mycobacterial infection. Rather, we conclude from our experiments that rlFN-3, in combination with M. bov/s BCG or LPS stimulated TNF-ot synthesis in BMM and that both cytokines were then required for IL-12 induction. Consistent with this assumption TNF-ot is produced in vitro by macrophages upon stimulation with rlFN-3, and mycobacterial infection and both cytokines are mandatory for activation of antimycobacterial macrophage functions (26) . Furthermore, TNF-c~ production in vivo in response to M. boris BCG infection is markedly impaired in IFN-3,R ~176 mutant mice (32) . Our results are in contrast to those by Reiner et al. (33) who described IL-12 m R N A expression in BMM treated with LPS alone. However, in this study, macrophages were cultivated in serum-containing medium and hence may have already been primed whereas our experiments were performed under serum-free conditions that yield resting macrophages. Formal proof for strict dependence on IFN-'y and TNF-c~ of IL-12 induction in mycobacterial infection in vivo was obtained in experiments using IFN-'yR ~176 and Tnfrl ~176 mice. In Schijns et al. (35) and Swihart et al. (36) have shown that infection of IFN-3,R ~176 mice with pseudorabies virus or L. major, respectively, leads to T h l cytokine profiles. We also found IFN-3' production by splenocytes ofM. bov/s BCGinfected IFN-3,R ~176 mice (data not shown). In contrast to pseudorabies virus infection, control ofM. bov/s BCG is IFN-3' dependent and lack of IFN-3, action is obviously not compensated by other cytokines. In the M. bov/s BCG system IFN-3'
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Flesch et al. production may only partially depend on IL-12 and other cytokines may compensate. Another possibility is that IFN-3, production occurs independently from IL-12.
Taken together, our data reveal that Ib12 is not the first cytokine generated after infection with M. bov/s BCG. Rather, we assume that IFN-3, primes macrophages for TNF-cz production and that both cytokines then induce II,-12 synthesis in response to mycobacterial infection. The cellular source of the IFN-3' produced immediately after mycobacterial infection independent from IL-12 remains to be defined. Whether this immediate early IFN-3' production is stimulated directly by mycobacteria or involves other cytokines such as IL-13 (33, 37) is currently under investigation.
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